Diego Fonstad
Oprichter bij Bullet Biotechnology, Inc.
Profiel
Diego Fonstad is the founder of Sutro Biopharma, Inc. (founded in 2004) and Bullet Biotechnology, Inc. (founded in 2011).
At Sutro Biopharma, he held the title of Vice President-Operations.
At Bullet Biotechnology, he held the title of Director.
Mr. Fonstad has an undergraduate degree from Harvard University and an MBA from Stanford University.
Actieve functies van Diego Fonstad
| Bedrijven | Functie | Begin |
|---|---|---|
Bullet Biotechnology, Inc.
 Bullet Biotechnology, Inc. BiotechnologyHealth Technology Bullet Biotechnology, Inc. develops active immunotherapies to stimulate a person’s own immune system to overcome diseases. Its technology educates the immune system to targeting specific cells that are causing disease. The firm's pipeline includes therapeutic vaccines for cancer, multi-specific antibody capsid products, therapeutic vaccines for autoimmune diseases, and other vaccines. The company was founded by Diego Fonstad, James R. Swartz, Willie Quinn and Thomas Theriault in September 2011 and is headquartered in Redwood City, CA. | Oprichter | 01-09-2011 |
Eerdere bekende functies van Diego Fonstad
| Bedrijven | Functie | Einde |
|---|---|---|
| SUTRO BIOPHARMA, INC. | Oprichter | - |
Opleiding van Diego Fonstad
| Harvard University | Undergraduate Degree |
| Stanford University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SUTRO BIOPHARMA, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Bullet Biotechnology, Inc.
Bullet Biotechnology, Inc. BiotechnologyHealth Technology Bullet Biotechnology, Inc. develops active immunotherapies to stimulate a person’s own immune system to overcome diseases. Its technology educates the immune system to targeting specific cells that are causing disease. The firm's pipeline includes therapeutic vaccines for cancer, multi-specific antibody capsid products, therapeutic vaccines for autoimmune diseases, and other vaccines. The company was founded by Diego Fonstad, James R. Swartz, Willie Quinn and Thomas Theriault in September 2011 and is headquartered in Redwood City, CA. | Health Technology |
